MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
June 18, 2021

FDA Approves Secukinumab for Children with Plaque Psoriasis

By Adam Hochron
The FDA has approved secukinumab to treat patients over the age of 6 who have moderate to severe plaque psoriasis and are eligible for systemic therapy or phototherapy...
FDA Approves Secukinumab for Children with Plaque Psoriasis
June 16, 2021

Isolated Bacterium in Healthy Skin May Be a Potential New Therapy for Atopic Dermatitis

By Jeff Craven /alert Contributor
Researchers have developed Staphylococcus hominis A9, skin bacteria normally harmless to most people, into a bacteriotherapy that may help patients with atopic dermatitis...
Isolated Bacterium in Healthy Skin May Be a Potential New Therapy for Atopic Dermatitis
June 15, 2021

SURPASS-4: Tirzepatide Reduces A1C, Body Weight in Type 2 Diabetes

By Dave Quaile, /alert Contributor
Treatment with tirzepatide reduced hemoglobin A1C and body weight from baseline compared with titrated insulin glargine among patients with type 2 diabetes with increased cardiovascular risk...
SURPASS-4: Tirzepatide Reduces A1C, Body Weight in Type 2 Diabetes
June 14, 2021

Adjuvant Chemotherapy Does Not Improve Survival in Locally Advanced Cervical Cancer

By Andrew John, /alert Contributor
Further chemotherapy following standard treatment failed to improve survival among patients with locally advanced cervical cancer...
Adjuvant Chemotherapy Does Not Improve Survival in Locally Advanced Cervical Cancer
June 11, 2021

FDA Clears Trial of Novel Electronic Device for Bladder Incontinence

By Andrew John, /alert Contributor
The FDA has approved an investigational device exemption trial for a novel therapy to alleviate bladder incontinence...
FDA Clears Trial of Novel Electronic Device for Bladder Incontinence
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

British study in children shows racial disparities in COVID-19 testing, outcomes

By Linda Carroll (Reuters Health) - Minority children in England were less likely to be tested for COVID-19, but more likely to be positive when tested, than white children, researchers there report. Read More »

FDA documents show struggle over approval of new Alzheimer's drug from Biogen

By Julie Steenhuysen (Reuters) - The U.S. Food and Drug Administration on Tuesday released a sweeping series of memos revealing a clear struggle within the agency ahead of its controversial decision Read More »

Levothyroxine remains common in U.S. for mildly increased thyrotropin

By Lisa Rapaport (Reuters Health) - Many U.S. patients taking levothyroxine started treatment when they had subclinical hypothyroidism and only mildly increased thyrotropin levels, a recent study Read More »

Alcohol tied to reduced fecundability, particularly at 3+ drinks a week

By Lisa Rapaport (Reuters Health) - Women who consume three or more drinks a week during the luteal phase of their menstrual cycle or more than six weekly drinks during the ovulatory window may Read More »

No benefit to therapeutic oral anticoagulation in COVID-19 hospitalizations

By Marilynn Larkin NEW YORK (Reuters Health) - In patients hospitalized with COVID-19 and elevated D-dimer concentrations, therapeutic dosing of oral anticoagulants did not improve outcomes compared Read More »

'Epsilon' variant not more common in mRNA-vaccinated healthcare workers

By Linda Carroll (Reuters Health) - SARS-CoV-2 breakthrough infections were rare in a cohort of fully vaccinated California healthcare workers and the Epsilon variant of concern was no more likely Read More »

Biomarker may predict neurological damage in COVID-19

By Marilynn Larkin NEW YORK (Reuters Health) - Concentrations of neurofilament light chain (NFL), a marker of neuroaxonal injury, predicted the extent of neuronal damage in a cohort of patients Read More »

Toxic PFAS taint lipsticks, mascaras and other makeup

By Ronnie Cohen (Reuters Health) - More than half the cosmetics sold in the United States and Canada have high levels of PFAS, chemicals associated with increased cancer risks, decreased vaccine Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information